CN Stock MarketDetailed Quotes

600557 Jiangsu Kanion Pharmaceutical

Watchlist
  • 14.50
  • +0.22+1.54%
Market Closed Nov 29 15:00 CST
8.44BMarket Cap15.49P/E (TTM)

Jiangsu Kanion Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-11.06%3.11B
-11.49%2.26B
0.48%1.36B
11.88%4.87B
11.86%3.5B
21.74%2.55B
25.39%1.35B
19.25%4.35B
20.97%3.13B
18.54%2.1B
Operating revenue
-11.06%3.11B
-11.49%2.26B
0.48%1.36B
11.88%4.87B
11.86%3.5B
21.74%2.55B
25.39%1.35B
19.25%4.35B
20.97%3.13B
18.54%2.1B
Other operating revenue
----
19.44%17.19M
----
2.98%28.27M
----
-28.18%14.4M
----
-21.44%27.46M
----
1.96%20.04M
Total operating cost
-10.71%2.77B
-10.61%2B
-0.30%1.19B
10.61%4.36B
10.50%3.1B
20.39%2.23B
25.15%1.19B
18.05%3.94B
20.38%2.81B
18.13%1.85B
Operating cost
-12.78%802.16M
-10.06%575.23M
2.48%345.11M
3.17%1.25B
0.48%919.75M
7.31%639.57M
9.42%336.77M
18.44%1.21B
20.89%915.38M
15.93%596.02M
Operating tax surcharges
-9.77%49.26M
-10.49%35.29M
13.64%21.55M
2.20%74.78M
2.80%54.59M
7.56%39.43M
4.83%18.96M
20.36%73.18M
22.13%53.11M
22.64%36.66M
Operating expense
-20.62%1.18B
-21.52%854.43M
-14.41%508.86M
3.70%1.94B
15.46%1.48B
26.32%1.09B
33.93%594.55M
17.99%1.87B
19.64%1.28B
18.72%861.83M
Administration expense
95.58%292.47M
91.07%210.09M
111.89%116.51M
83.04%347.04M
22.52%149.54M
29.09%109.95M
48.60%54.99M
16.84%189.6M
7.67%122.06M
8.97%85.18M
Financial expense
-20.56%-18.44M
-128.23%-17.97M
-179.01%-9.14M
-160.96%-23.06M
-191.97%-15.3M
-261.57%-7.87M
-1,217.02%-3.28M
-207.70%-8.84M
-171.95%-5.24M
-140.14%-2.18M
-Interest expense (Financial expense)
----
----
----
----
----
-97.65%32.78K
----
-82.84%1.91M
-83.83%1.41M
-76.97%1.4M
-Interest Income (Financial expense)
-14.72%-18.81M
-118.89%-18.27M
-168.99%-9.33M
-119.37%-24.45M
-122.26%-16.39M
-94.93%-8.35M
-126.37%-3.47M
-211.16%-11.15M
-290.51%-7.38M
-335.70%-4.28M
Research and development
-8.48%466.74M
-6.67%339.2M
8.24%204.12M
27.40%771.69M
16.67%510.01M
31.02%363.45M
30.78%188.58M
21.29%605.73M
29.78%437.12M
28.01%277.4M
Credit Impairment Loss
144.45%490.39K
74.99%-467.89K
-109.94%-690.85K
94.34%-120.01K
-3.06%-1.1M
-595.56%-1.87M
2,294.65%6.95M
-472.21%-2.12M
-452.56%-1.07M
153.05%377.55K
Asset Impairment Loss
----
----
----
-631.95%-2.77M
----
----
----
-64.55%521K
----
----
Other net revenue
55.91%82.42M
120.11%48.99M
-7.39%10.59M
22.79%55.9M
111.34%52.86M
49.94%22.26M
45.42%11.43M
10.53%45.52M
58.26%25.01M
46.05%14.84M
Invest income
55.32%10.26M
556.06%6.11M
1,246.80%6.03M
252.36%14.79M
98.50%6.61M
-63.33%932.07K
-60.25%447.98K
3.51%4.2M
34.33%3.33M
37.03%2.54M
-Including: Investment income associates
-73.75%5.42K
-73.75%5.42K
----
-49.42%20.9K
-1.90%20.66K
-1.90%20.66K
----
109.86%41.32K
-5.00%21.06K
-5.00%21.06K
Asset deal income
2,537.79%703.69K
2,537.79%703.69K
---55.32K
-45.12%757.74K
-102.44%-28.87K
-12,033.04%-28.87K
----
42.98%1.38M
-16.35%1.18M
-100.41%-237.91
Other revenue
49.74%70.96M
83.60%42.64M
31.36%5.3M
4.08%43.24M
119.68%47.39M
94.76%23.23M
-37.38%4.04M
21.74%41.54M
78.20%21.57M
33.05%11.93M
Operating profit
-5.54%422.3M
-8.68%312.51M
5.33%182.59M
23.96%563.79M
30.17%447.06M
33.11%342.23M
28.22%173.36M
29.58%454.81M
28.38%343.45M
23.00%257.11M
Add:Non operating Income
738.72%11.78M
900.43%10.81M
353.86%954.06K
84.80%6.16M
-55.45%1.4M
-61.85%1.08M
51.13%210.21K
432.47%3.33M
561.12%3.15M
407.81%2.83M
Less:Non operating expense
-49.21%6.82M
-24.00%6.51M
306.21%5.95M
52.64%18.96M
33.73%13.42M
-2.11%8.56M
-64.06%1.46M
-46.77%12.42M
-43.58%10.04M
-49.29%8.75M
Total profit
-1.79%427.26M
-5.36%316.81M
3.19%177.6M
23.62%550.98M
29.26%435.04M
33.26%334.75M
31.11%172.11M
35.78%445.72M
34.51%336.56M
30.60%251.2M
Less:Income tax cost
-15.96%63.28M
-12.23%45.52M
4.47%28.03M
3.52%3.93M
43.17%75.29M
30.19%51.86M
28.43%26.83M
-2.99%3.8M
32.13%52.59M
29.76%39.83M
Net profit
1.18%363.98M
-4.10%271.3M
2.96%149.57M
23.79%547.05M
26.69%359.75M
33.84%282.89M
31.61%145.27M
36.25%441.92M
34.96%283.97M
30.77%211.36M
Net profit from continuing operation
1.18%363.98M
-4.10%271.3M
2.96%149.57M
23.79%547.05M
26.69%359.75M
33.84%282.89M
31.61%145.27M
36.25%441.92M
34.96%283.97M
30.77%211.36M
Less:Minority Profit
-33.14%6.84M
-18.08%5.87M
-60.28%1.52M
38.47%10.32M
287.96%10.23M
2,842.63%7.17M
875.32%3.83M
95.72%7.45M
-19.81%2.64M
-88.52%243.6K
Net profit of parent company owners
2.18%357.14M
-3.73%265.42M
4.67%148.04M
23.54%536.73M
24.24%349.53M
30.60%275.72M
28.60%141.44M
35.54%434.47M
35.83%281.34M
32.35%211.12M
Earning per share
Basic earning per share
1.64%0.62
-2.13%0.46
4.00%0.26
24.00%0.93
24.49%0.61
27.03%0.47
31.58%0.25
33.93%0.75
36.11%0.49
32.14%0.37
Diluted earning per share
3.33%0.62
-2.13%0.46
4.17%0.25
24.00%0.93
22.45%0.6
27.03%0.47
26.32%0.24
33.93%0.75
36.11%0.49
32.14%0.37
Other composite income
Total composite income
1.18%363.98M
-4.10%271.3M
2.96%149.57M
23.79%547.05M
26.69%359.75M
33.84%282.89M
31.61%145.27M
36.25%441.92M
34.96%283.97M
30.77%211.36M
Total composite income of parent company owners
2.18%357.14M
-3.73%265.42M
4.67%148.04M
23.54%536.73M
24.24%349.53M
30.60%275.72M
28.60%141.44M
35.54%434.47M
35.83%281.34M
32.35%211.12M
Total composite income of minority owners
-33.14%6.84M
-18.08%5.87M
-60.28%1.52M
38.47%10.32M
287.96%10.23M
2,842.63%7.17M
875.32%3.83M
95.72%7.45M
-19.81%2.64M
-88.52%243.6K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -11.06%3.11B-11.49%2.26B0.48%1.36B11.88%4.87B11.86%3.5B21.74%2.55B25.39%1.35B19.25%4.35B20.97%3.13B18.54%2.1B
Operating revenue -11.06%3.11B-11.49%2.26B0.48%1.36B11.88%4.87B11.86%3.5B21.74%2.55B25.39%1.35B19.25%4.35B20.97%3.13B18.54%2.1B
Other operating revenue ----19.44%17.19M----2.98%28.27M-----28.18%14.4M-----21.44%27.46M----1.96%20.04M
Total operating cost -10.71%2.77B-10.61%2B-0.30%1.19B10.61%4.36B10.50%3.1B20.39%2.23B25.15%1.19B18.05%3.94B20.38%2.81B18.13%1.85B
Operating cost -12.78%802.16M-10.06%575.23M2.48%345.11M3.17%1.25B0.48%919.75M7.31%639.57M9.42%336.77M18.44%1.21B20.89%915.38M15.93%596.02M
Operating tax surcharges -9.77%49.26M-10.49%35.29M13.64%21.55M2.20%74.78M2.80%54.59M7.56%39.43M4.83%18.96M20.36%73.18M22.13%53.11M22.64%36.66M
Operating expense -20.62%1.18B-21.52%854.43M-14.41%508.86M3.70%1.94B15.46%1.48B26.32%1.09B33.93%594.55M17.99%1.87B19.64%1.28B18.72%861.83M
Administration expense 95.58%292.47M91.07%210.09M111.89%116.51M83.04%347.04M22.52%149.54M29.09%109.95M48.60%54.99M16.84%189.6M7.67%122.06M8.97%85.18M
Financial expense -20.56%-18.44M-128.23%-17.97M-179.01%-9.14M-160.96%-23.06M-191.97%-15.3M-261.57%-7.87M-1,217.02%-3.28M-207.70%-8.84M-171.95%-5.24M-140.14%-2.18M
-Interest expense (Financial expense) ---------------------97.65%32.78K-----82.84%1.91M-83.83%1.41M-76.97%1.4M
-Interest Income (Financial expense) -14.72%-18.81M-118.89%-18.27M-168.99%-9.33M-119.37%-24.45M-122.26%-16.39M-94.93%-8.35M-126.37%-3.47M-211.16%-11.15M-290.51%-7.38M-335.70%-4.28M
Research and development -8.48%466.74M-6.67%339.2M8.24%204.12M27.40%771.69M16.67%510.01M31.02%363.45M30.78%188.58M21.29%605.73M29.78%437.12M28.01%277.4M
Credit Impairment Loss 144.45%490.39K74.99%-467.89K-109.94%-690.85K94.34%-120.01K-3.06%-1.1M-595.56%-1.87M2,294.65%6.95M-472.21%-2.12M-452.56%-1.07M153.05%377.55K
Asset Impairment Loss -------------631.95%-2.77M-------------64.55%521K--------
Other net revenue 55.91%82.42M120.11%48.99M-7.39%10.59M22.79%55.9M111.34%52.86M49.94%22.26M45.42%11.43M10.53%45.52M58.26%25.01M46.05%14.84M
Invest income 55.32%10.26M556.06%6.11M1,246.80%6.03M252.36%14.79M98.50%6.61M-63.33%932.07K-60.25%447.98K3.51%4.2M34.33%3.33M37.03%2.54M
-Including: Investment income associates -73.75%5.42K-73.75%5.42K-----49.42%20.9K-1.90%20.66K-1.90%20.66K----109.86%41.32K-5.00%21.06K-5.00%21.06K
Asset deal income 2,537.79%703.69K2,537.79%703.69K---55.32K-45.12%757.74K-102.44%-28.87K-12,033.04%-28.87K----42.98%1.38M-16.35%1.18M-100.41%-237.91
Other revenue 49.74%70.96M83.60%42.64M31.36%5.3M4.08%43.24M119.68%47.39M94.76%23.23M-37.38%4.04M21.74%41.54M78.20%21.57M33.05%11.93M
Operating profit -5.54%422.3M-8.68%312.51M5.33%182.59M23.96%563.79M30.17%447.06M33.11%342.23M28.22%173.36M29.58%454.81M28.38%343.45M23.00%257.11M
Add:Non operating Income 738.72%11.78M900.43%10.81M353.86%954.06K84.80%6.16M-55.45%1.4M-61.85%1.08M51.13%210.21K432.47%3.33M561.12%3.15M407.81%2.83M
Less:Non operating expense -49.21%6.82M-24.00%6.51M306.21%5.95M52.64%18.96M33.73%13.42M-2.11%8.56M-64.06%1.46M-46.77%12.42M-43.58%10.04M-49.29%8.75M
Total profit -1.79%427.26M-5.36%316.81M3.19%177.6M23.62%550.98M29.26%435.04M33.26%334.75M31.11%172.11M35.78%445.72M34.51%336.56M30.60%251.2M
Less:Income tax cost -15.96%63.28M-12.23%45.52M4.47%28.03M3.52%3.93M43.17%75.29M30.19%51.86M28.43%26.83M-2.99%3.8M32.13%52.59M29.76%39.83M
Net profit 1.18%363.98M-4.10%271.3M2.96%149.57M23.79%547.05M26.69%359.75M33.84%282.89M31.61%145.27M36.25%441.92M34.96%283.97M30.77%211.36M
Net profit from continuing operation 1.18%363.98M-4.10%271.3M2.96%149.57M23.79%547.05M26.69%359.75M33.84%282.89M31.61%145.27M36.25%441.92M34.96%283.97M30.77%211.36M
Less:Minority Profit -33.14%6.84M-18.08%5.87M-60.28%1.52M38.47%10.32M287.96%10.23M2,842.63%7.17M875.32%3.83M95.72%7.45M-19.81%2.64M-88.52%243.6K
Net profit of parent company owners 2.18%357.14M-3.73%265.42M4.67%148.04M23.54%536.73M24.24%349.53M30.60%275.72M28.60%141.44M35.54%434.47M35.83%281.34M32.35%211.12M
Earning per share
Basic earning per share 1.64%0.62-2.13%0.464.00%0.2624.00%0.9324.49%0.6127.03%0.4731.58%0.2533.93%0.7536.11%0.4932.14%0.37
Diluted earning per share 3.33%0.62-2.13%0.464.17%0.2524.00%0.9322.45%0.627.03%0.4726.32%0.2433.93%0.7536.11%0.4932.14%0.37
Other composite income
Total composite income 1.18%363.98M-4.10%271.3M2.96%149.57M23.79%547.05M26.69%359.75M33.84%282.89M31.61%145.27M36.25%441.92M34.96%283.97M30.77%211.36M
Total composite income of parent company owners 2.18%357.14M-3.73%265.42M4.67%148.04M23.54%536.73M24.24%349.53M30.60%275.72M28.60%141.44M35.54%434.47M35.83%281.34M32.35%211.12M
Total composite income of minority owners -33.14%6.84M-18.08%5.87M-60.28%1.52M38.47%10.32M287.96%10.23M2,842.63%7.17M875.32%3.83M95.72%7.45M-19.81%2.64M-88.52%243.6K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data